Ligand Pharmaceuticals CLO and Secretary Andrew Reardon sells USD 1.43 million in common shares
LGND•Insider share sales
- Ligand Pharmaceuticals CLO and Secretary Andrew Reardon sold 5,000 shares on Sept. 3.
- Sales were priced at about $283.99 to $288.98 per share.
- The directly held stake fell to 36,514 shares after the transactions.
